US Pharma MarketingEU reaches provisional deal on Critical Medicines Act
The Critical Medicines Act reached its next milestone on Tuesday, after the European Parliament and the Council provisionally voted it through. Topic Hubs AI drug discovery: News, analysis and interviews Antibody-drug conjugates: The next wave of targeted cancer drugs Biopharma M&A and dealmaking: Who’s buying and why Biopharma people moves: CEO changes, executive hires, board positions Biotech IPOs: Tracking the market for new public offerings Biotech venture funding: Who’s raising and where the money is going Cell and gene therapy manufacturing: Scaling the next frontier China biotech: Licensing deals and the Biosecure Act CRISPR and gene editing: The push for…
The Critical Medicines Act reached its next milestone on Tuesday, after the European Parliament and the Council provisionally voted it through.
The proposed regulation aims to improve the European Union’s supply chains for critical medicines ...
Source: Endpoints News